Advertisement

Old and emerging concepts on adrenal chromaffin cell stimulus-secretion coupling

  • Ricardo Borges
  • Luis Gandía
  • Emilio CarboneEmail author
Editorial

Abstract

The chromaffin cells (CCs) of the adrenal medulla play a key role in the control of circulating catecholamines to adapt our body function to stressful conditions. A huge research effort over the last 35 years has converted these cells into the Escherichia coli of neurobiology. CCs have been the testing bench for the development of patch-clamp and amperometric recording techniques and helped clarify most of the known molecular mechanisms that regulate cell excitability, Ca2+ signals associated with secretion, and the molecular apparatus that regulates vesicle fusion. This special issue provides a state-of-the-art on the many well-known and unsolved questions related to the molecular processes at the basis of CC function. The issue is also the occasion to highlight the seminal work of Antonio G. García (Emeritus Professor at UAM, Madrid) who greatly contributed to the advancement of our present knowledge on CC physiology and pharmacology. All the contributors of the present issue are distinguished scientists who are either staff members, external collaborators, or friends of Prof. García.

The early studies

Adrenal chromaffin cells (CCs) together with the sympathetic nervous system are the main sources of catecholamines that our body mobilizes for the “fight or flight” response during fear, stress, exercise, or conflict conditions. During the response, the body is prepared to achieve maximal strength and awareness by increasing heart work and blood pressure. Vasodilation and vasoconstriction are regulated in a way that the skeletal muscles and the heart receive more blood while peripheral and gastrointestinal blood supply is attenuated. Glucose is mobilized from the liver while bronchioles and pupils dilate to improve respiration and increase visual acuity.

CCs contribute massively to the fight or flight response by mainly secreting adrenaline into the bloodstream after the release of acetylcholine (ACh) from preganglionic splanchnic fibers. W. Feldberg was the first to identify ACh as the primary neurotransmitter triggering adrenaline and noradrenaline release [29] while W. W. Douglas coined the term “stimulus-secretion coupling” to describe the release of catecholamines following the activation of nicotinic receptors by ACh [28]. This latter also identified Ca2+ as the main extracellular ion involved in the secretagogue action of ACh.

Chromaffin cell physiology has been widely studied since then. Early studies (1965–1981) focused on the role of nicotinic (nAChR) and muscarinic (mAChR) receptors in regulating the CC response to ACh [27, 68] (see the reviews by Albillos and McIntosh, Inoue and Kao, and Criado in this issue). Great interest was also dedicated to clarify how vesicle secretion was regulated by extracellular Ca2+ flows [5] and which molecules, besides adrenaline and noradrenaline, were packed in the large dense core (LDC) secretory granules and released during activity [45]. It was evident that chromaffin cells were excitable cells like neurons and thus able to generate action potentials (APs) sustained by voltage-gated Na+ and K+ channels [6, 11] and that most of the Ca2+ required for the exocytosis entered the cell through not yet fully identified voltage-gated Ca2+ channels [10, 12].

Of great interest during this period was also the identification of the cytoskeletal protein components (f-actin and myosin) that are the major constituents of cytoplasmic microfilaments along which LDC vesicles move from inside the cell, where they are stored, to the plasmalemma where they are docked and fused [32, 67]. Of enormous interest was also the first report on the existence of the intravesicular protein chromogranin A (CgA) in the mid-1960s [7]. The initial idea was that CgA served as a colligative agent for reducing the osmotic forces resulting from the large accumulation of solutes in large dense core vesicles. Later, chromogranin B and chromogranin C (secretogranin II) have been added to the list that currently includes nine members [26].

Thirty-five years of amazing discoveries (1982–2017)

Ion channels, receptors, neurotransmitters, and gap junctions regulating chromaffin cell activity

As for other neuroendocrine cells, adrenal chromaffin cells gained greatly from the advent of the patch-clamp technique [38]. The approach allowed to identify the gating properties of a large number of Na+, K+, and Ca2+ channels that regulate AP firing and catecholamine secretion [30]. Meanwhile, Na+, K+, and Ca2+ channels where identified by DNA sequencing and newly available blockers, in CCs, it was possible to establish the presence of a voltage-gated Na+ channel (Nav1.7) [31], several voltage-gated (Kv) [50, 62] and Ca2+-gated K+ channels (SK, BK) [55], and a number of voltage-gated Ca2+ channels (L, N, and P/Q-type) [33, 69]. The Madrid group of Antonio García was particularly active in these studies. It was the first to identify the key role of L-type calcium channels (Cav1.2, Cav1.3) in controlling catecholamine secretion in cat CCs [34] (see the review by Nanclares et al. in this issue) and to uncover variable densities of P/Q- (Cav2.1) and N-type (Cav2.2) in bovine, cat, rat, mouse, and human CCs that contribute differently to secretion [33]. Rat and mouse CCs express also R-type channels (Cav2.3) sensitive to SNX-482 [3, 47] and T-type channels (Cav3.2) that are effectively coupled to the secretory apparatus [15, 16]. The role of each ion channel in CC excitability is still debated but it is now clear that their expression and regulation are key factors to set the neuron-like firing modes of CCs [69] (see the review by Lingle et al. in this issue).

Besides muscarinic receptors, CCs were found to express a large variety of G protein-coupled receptors (GPCRs) that are autocrinally activated by the released products of the same cells [17, 23, 33]. This action was of great interest to understand CC function and boosted a massive work of several laboratories that brought to the identification of α- and β-adrenergic (see the review by Artalejo et al. in this issue), δ-opioidergic, P2y-purinergic, and GABA receptors (see the review by Alejandre-García et al. in this issue). Most of them are effectively activated by the neurotransmitter molecules released by CCs (ATP, opioids, A, NA) and induce a marked depression of Ca2+ currents. Here also, the Madrid group was determinant in demonstrating that the purified content of secretory vesicles (soluble vesicle lysate) when applied on bovine CCs had a potent voltage-dependent depressive action on N- and P/Q-type Ca2+ currents (Cav2.1, Cav2.2) that was prevented by mixtures of broad spectrum opioidergic and purinergic antagonists [2, 33]. L-type channels (Cav1.2 and Cav1.3) are also autocrinally modulated by β1- and β2-AR but the action is voltage independent and can be either depressive or potentiating [18]. Apart from the L-type channel upregulation by β-AR stimulation, most pathways of Cav channel modulation serve as a negative feedback inhibition to regulate catecholamine secretion in CCs [23].

CCs express also GPCRs selective for the pituitary adenylate cyclase-activating polypeptide (PACAP), a 38-amino acid peptide [70] co-released with ACh from preganglionic splanchnic nerve fibers during sympathetic stimulation [20, 72, 73]. PACAP is able to sustain catecholamine release from CCs even during sustained depolarizations and to lead to CC gene transcription [63]. Since PACAP and its receptors are broadly expressed in the central nervous system, in particular in the hypothalamic-pituitary-adrenocortical axis, the neurotransmitter is proposed as a “master regulator” of stress signaling throughout the nervous system [65] (see the review by Eiden et al. in this issue).

Since the first morphological observations on adrenomedullary cells, it was evident that CCs are in contact with each other and grouped in clusters of either adrenergic or noradrenergic cells [22]. These functional units are differentially innervated [43] and electrically coupled by gap junctions [49] forming an excellent model for studying the molecular components of cell-to-cell communication (see the review by Guerineau in this issue).

Vesicle exocytosis viewed through cell capacitance changes, amperometric recordings, and fluorescence microscopy

The advent of patch-clamp techniques allowed also an impressive breakthrough into CC function, allowing a direct measurement of the Ca2+-dependent neurosecretion during cell stimulation. By measuring the increase of cell surface as membrane capacity changes (∆C) during exocytosis, it was possible to correlate Ca2+ entry to the amount of vesicles that fuse and release catecholamines during stimulation [56]. Alternating pulses of Ca2+ loading and ∆C measurements made it possible to determine, with high-time resolution, key parameters such as the amount of “release-ready” vesicles, the probability of vesicle release, and the quantal size of single secretory events in bovine CCs [35, 39]. In mouse CCs, ∆C recordings combined with Ca2+-uncaging experiments also allowed to obtain a clear picture of the vesicle distribution at rest and during stimulus-secretion coupling with high-time resolution. Erwin Neher’s group could resolve the presence of four different pools of vesicles in dynamic equilibrium among each other (see the review by Neher in this issue). A reserve (depot) pool, containing many vesicles (2000 to 4000) in slow equilibrium with an unprimed pool (UPP) of 650 vesicles, a slowly releasable pool (SRP), and a ready-releasable pool (RRP) of about 100 vesicles each were close to the membrane [60, 71]. Movements from the UPP to the SRP and RRP lead to vesicle docking, priming, and fusion and terminate with the emptying of the vesicle content. All these sequential events are common to neurons and CCs (for a review, see [40] and Dhara et al. in this issue) and are regulated by the formation of the four-helix SNARE complex (syntaxin, synatobrevin, and SNAP25) and by the interaction of SNARE with the priming protein Munc13-1 and the Ca2+ sensor synaptotagmin [60]. In this regard, the studies on CCs using the fast time resolution of ∆C recordings in combination with KO mice models have been crucial in identifying the role of each molecular player on the sequence of events regulating stimulus-secretion coupling (see the review by Cardenas and Marengo in this issue).

Studies on CC function were further boosted by adapting electrochemical methods to measure the oxidation currents generated by specific released neurotransmitters. Using carbon fiber microelectrodes, it was possible to demonstrate that pressure ejections of ACh induce brief spikes of oxidative currents associated with the release of catecholamines in bovine CCs [44, 74]. Amperometric and voltammetric recordings broadened the present knowledge of cell exocytosis. Cyclic voltammetry allowed identifying the type of biological amines released (adrenaline, noradrenaline, histamine, or serotonin) while amperometry helped resolve bursts of quantal secretory events during stimulus-secretion coupling and to distinguish the kinetics of vesicle fusion (foot) and neurotransmitter release (amperometric peak) during single events (for a review, see [8, 25, 66]). Bovine and mouse CCs have been the ideal cells for studying the role that SNARE-related and cytoskeletal proteins play on the regulation of vesicle transport, priming, and fusion using either amperometric recordings alone [37, 54] or in combination with whole-cell capacitance and Ca2+-uncaging measurements [9, 57, 64]. Amperometry has been determinant also in demonstrating many key biophysical and pharmacological properties of exocytosis. Among them, it is worth recalling the well-accepted evidence that (i) fusion pore is permeable to catecholamines [19], (ii) secretion occurs in spatially localized microareas of CCs (hot spots) [36, 61], and (iii) PKG, PKA, and PKC are effective modulators of exocytosis [37, 46]. Of interest are also recent observations that the quantal size is regulated by VMAT and autoreceptors [21, 33] and vesicular pH regulates the kinetics and quantal size of chromaffin cell granules [14]. Amperometry has been also successfully employed to correlate changes in the kinetics of exocytosis and quantal size with changes in the content of other soluble species co-stored with catecholamines that contribute to granule homeostasis (see the review by Borges et al. in this issue).

Since the early observations that actin and myosin are the main components of neurofilaments in CCs, the present view of cytoskeleton protein function has progressively evolved. In the 1980s, the presence of filamentous actin (F-actin) was simply interpreted as a peripheral cortical barrier of proteins preventing vesicle access to the secretory sites [4, 13]. At the beginning of this century, with the availability of more advanced immunofluorescence techniques, it became apparent that F-actin also participated in vesicle transport and fusion in addition to its original “retentive” role [41, 53, 59]. Recent evidence on adrenal gland slices suggests that F-actin has an even more complex function than expected and that the traditional 2D primary cell culture arrangement usually employed for these studies does not accurately mimic the 3D in vivo environment (see the review by Gutiérrez et al. in this issue).

Chromaffin cells for testing new materials for amperometric microdevices

Because of the many electrochemical active species stored in the secretory granules, CCs are still the favorite cell model to test novel approaches and materials for fabricating electrochemical devices and lab-on-chips currently used for drug screening (see the review by Gillis et al. and the research article by Huang et al. in this issue). From the time when electrochemical detectors were firstly implemented as sensors for HPLC to date, their sizes have been progressively reduced to allow on-cell recordings as conventional amperometry [66], microelectrode fabrication for patch amperometry [1], and intracellular electrochemistry [52]. This tendency persists and miniaturization is currently used for studying secretory vesicles inside living CCs (see the review by Cans in this issue).

Chromaffin cells for studying cardiovascular and neurodegenerative diseases

Although recent research has precisely defined the roles of chromogranins (Cgs) in the storage of catecholamines [26], these proteins are shown to possess new key physiological roles. Cgs are now recognized to be the precursors of several active peptides involved in the regulation of glycemia, blood pressure, or innate immunity (see the review by Helle et al. in this issue). Recent studies have shown that CCs can produce granules in animals lacking CgA [51], thus proving that CgA is not critical for granulogenesis. Indeed, Cgs are sufficient to trigger functional granule production and sorting even in non-secretory cells [26]. Interestingly, Cgs are now widely used as clinical markers for cardiovascular, gastrointestinal, and inflammatory diseases [42]. Since the pioneering work of D. T. O’Connor [58], the presence of large plasma concentrations of Cgs is a key diagnostic and prognostic tool of several tumors (see the review by Corti et al. in this issue).

CCs are also widely used as a model system for studying diseases. The presence of abnormal blood catecholamines is still the most reliable test for the diagnosis of pheochromocytoma. In addition, CCs are considered paraneurons and as such have been exploited for studying hypersympathetic activity and hypertension as well as neurotoxic mechanisms and neuroprotective drugs [48] (see the review by de los Ríos et al. in this issue). CCs are currently used to investigate the altered neurotransmission mechanism induced by Parkinson’s and Alzheimer’s diseases [24].

Future perspectives on chromaffin cells in health and disease

Despite the great advances of our acquaintance on the biology, biochemistry, physiology, pharmacology, and pathology of chromaffin cells described above, there are still many critical issues that remain unsolved and require future work. They are all of great interest, particularly in the view of the critical role that CCs play in the control of circulating catecholamines and other hormones during physiological stress conditions. In addition to this, it is worth mentioning that with the increased availability of transgenic animal models, mouse CCs have further attracted the attention of researchers in using these cells as a model system for studying stimulus-secretion coupling. Indeed, in mouse CCs, it is possible to combine excellent voltage-clamp recording of ion currents with high-time resolution whole-cell capacitance measurements and amperometric spike detection to obtain simultaneously, on the same cell, Ca2+ current injection and secretory event recordings in the forms of the number of vesicles fused (capacitance) and quantal release of catecholamines (amperometry). A condition that is unlikely in most neuroendocrine cells or neuronal presynaptic terminals.

This special issue of Pflügers Archiv contains a collection of review articles plus an original article that covers nearly all the key issues described above on chromaffin cell function. All of them highlight the past drawbacks and scientific improvements and indicate new future perspectives worthy of investigation. The authors are all well-distinguished scientists who are working on chromaffin cells and are good friends of Antonio García to whom this issue is dedicated.

The contributors of this special issue and many other colleagues, who were not invited only due to space limitation, meet every 2 years since 1982, when the 1st International Symposium on Chromaffin Cell Biology (ISCCB) took place in Ibiza (Spain). The ISCCB meetings are a great occasion for presenting, discussing, and advertising the new findings on chromaffin and its “sister” cells. The group met last August in occasion of the 19th ISCCB in Sheffield (UK) (https://www.sheffield.ac.uk/isccb) and the next ISCCB meeting will take place on January 2020 at the Indian Institute of Technology in Madras (India). We are looking forward to meeting you there!

References

  1. 1.
    Albillos A, Dernick G, Horstmann H, Almers W, Alvarez de Toledo G, Lindau M (1997) The exocytotic event in chromaffin cells revealed by patch amperometry. Nature 389:509–512CrossRefPubMedGoogle Scholar
  2. 2.
    Albillos A, Gandia L, Michelena P, Gilabert JA, del Valle M, Carbone E, Garcia AG (1996) The mechanism of calcium channel facilitation in bovine chromaffin cells. J Physiol 494:687–695CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Albillos A, Neher E, Moser T (2000) R-Type Ca2+ channels are coupled to the rapid component of secretion in mouse adrenal slice chromaffin cells. J Neurosci 20:8323–8330PubMedGoogle Scholar
  4. 4.
    Aunis D, Bader MF (1988) The cytoskeleton as a barrier to exocytosis in secretory cells. J Exp Biol 139:253–266PubMedGoogle Scholar
  5. 5.
    Baker PF, Knight DE (1978) Calcium-dependent exocytosis in bovine adrenal medullary cells with leaky plasma membranes. Nature 276:620–622CrossRefPubMedGoogle Scholar
  6. 6.
    Biales B, Dichter M, Tischler A (1976) Electrical excitability of cultured adrenal chromaffin cells. J Physiol 262:743–753CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Blaschko H, Comline RS, Schneider FH, Silver M, Smith AD (1967) Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 215:58–59CrossRefPubMedGoogle Scholar
  8. 8.
    Borges R, Camacho M, Gillis KD (2008) Measuring secretion in chromaffin cells using electrophysiological and electrochemical methods. Acta Physiol (Oxf) 192:173–184CrossRefGoogle Scholar
  9. 9.
    Borisovska M, Zhao Y, Tsytsyura Y, Glyvuk N, Takamori S, Matti U, Rettig J, Sudhof T, Bruns D (2005) v-SNAREs control exocytosis of vesicles from priming to fusion. EMBO J 24:2114–2126CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Bourne GW, Trifaro JM (1982) The gadolinium ion: a potent blocker of calcium channels and catecholamine release from cultured chromaffin cells. Neuroscience 7:1615–1622CrossRefPubMedGoogle Scholar
  11. 11.
    Brandt BL, Hagiwara S, Kidokoro Y, Miyazaki S (1976) Action potentials in the rat chromaffin cell and effects of acetylcholine. J Physiol 263:417–439CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Bresnahan SJ, Baugh LE, Borowitz JL (1980) Mechanisms of La3+-induced adrenal catecholamine release. Res Commun Chem Pathol Pharmacol 28:229–244PubMedGoogle Scholar
  13. 13.
    Burgoyne RD, Cheek TR (1987) Reorganisation of peripheral actin filaments as a prelude to exocytosis. Biosci Rep 7:281–288CrossRefPubMedGoogle Scholar
  14. 14.
    Camacho M, Machado JD, Montesinos MS, Criado M, Borges R (2006) Intragranular pH rapidly modulates exocytosis in adrenal chromaffin cells. J Neurochem 96:324–334CrossRefPubMedGoogle Scholar
  15. 15.
    Carabelli V, Marcantoni A, Comunanza V, De Luca A, Diaz J, Borges R, and Carbone E. Chronic hypoxia up-regulates alpha(1H) T-type channels and low-threshold catecholamine secretion in rat chromaffin cells. J Physiol 584: 149–165, 2007Google Scholar
  16. 16.
    Carbone E, Calorio C, Vandael DH (2014) T-type channel-mediated neurotransmitter release. Pflugers Arch 466:677–687CrossRefPubMedGoogle Scholar
  17. 17.
    Carbone E, Carabelli V, Cesetti T, Baldelli P, Hernandez-Guijo JM, Giusta L (2001) G-protein- and cAMP-dependent L-channel gating modulation: a manyfold system to control calcium entry in neurosecretory cells. Pflugers Archiv-European Journal of Physiology 442:801–813CrossRefPubMedGoogle Scholar
  18. 18.
    Cesetti T, Hernandez-Guijo JM, Baldelli P, Carabelli V, Carbone E (2003) Opposite action of beta 1- and beta 2-adrenergic receptors on Ca(V)1 L-channel current in rat adrenal chromaffin cells. J Neurosci 23:73–83PubMedGoogle Scholar
  19. 19.
    Chow RH, von Ruden L, and Neher E. Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells. Nature 356: 60–63, 1992Google Scholar
  20. 20.
    Chowdhury PS, Guo X, Wakade TD, Przywara DA, Wakade AR (1994) Exocytosis from a single rat chromaffin cell by cholinergic and peptidergic neurotransmitters. Neuroscience 59:1–5CrossRefPubMedGoogle Scholar
  21. 21.
    Colliver TL, Pyott SJ, Achalabun M, Ewing AG (2000) VMAT-mediated changes in quantal size and vesicular volume. J Neurosci 20:5276–5282PubMedGoogle Scholar
  22. 22.
    Coupland RE, Pyper AS, Hopwood D (1964) A method for differentiating between noradrenaline- and adrenaline-storing cells in the light and electron microscope. Nature 201:1240–1242CrossRefPubMedGoogle Scholar
  23. 23.
    Currie KP (2010) Inhibition of Ca2+ channels and adrenal catecholamine release by G protein coupled receptors. Cell Mol Neurobiol 30:1201–1208CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    de Diego AM, Lorrio S, Calvo-Gallardo E, and Garcia AG. Smaller quantal size and faster kinetics of single exocytotic events in chromaffin cells from the APP/PS1 mouse model of Alzheimer’s disease. Biochem Biophys Res Commun 428: 482–486, 2012Google Scholar
  25. 25.
    Dernick G, de Toledo GA, and Lindau M. The patch amperometry technique: design of a method to study exocytosis of single vesicles. In: Electrochemical methods for neuroscience, edited by Michael AC, and Borland LM. Boca Raton (FL): CRC Press/Taylor & Francis Group, LLC., 2007Google Scholar
  26. 26.
    Dominguez N, Estevez-Herrera J, Pardo MR, Pereda D, Machado JD, Borges R (2012) The functional role of chromogranins in exocytosis. J Mol Neurosci 48:317–322CrossRefPubMedGoogle Scholar
  27. 27.
    Douglas WW, Poisner AM (1965) Preferential release of adrenaline from the adrenal medulla by muscarine and pilocarpine. Nature 208:1102–1103CrossRefPubMedGoogle Scholar
  28. 28.
    Douglas WW, Rubin RP (1961) The role of calcium in the secretory response of the adrenal medulla to acetylcholine. J Physiol 159:40–57CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Feldberg W, Minz B, Tsudzimura H (1934) The mechanism of the nervous discharge of adrenaline. J Physiol 81:286–304CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Fenwick EM, Marty A, Neher E (1982) A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. J Physiol 331:577–597CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Fenwick EM, Marty A, Neher E (1982) Sodium and calcium channels in bovine chromaffin cells. J Physiol 331:599–635CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Fowler VM, Pollard HB (1982) Chromaffin granule membrane-F-actin interactions are calcium sensitive. Nature 295:336–339CrossRefPubMedGoogle Scholar
  33. 33.
    Garcia AG, Garcia-De-Diego AM, Gandia L, Borges R, Garcia-Sancho J (2006) Calcium signaling and exocytosis in adrenal chromaffin cells. Physiol Rev 86:1093–1131CrossRefPubMedGoogle Scholar
  34. 34.
    Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L (1984) Dihydropyridine BAY-K-8644 activates chromaffin cell calcium channels. Nature 309:69–71CrossRefPubMedGoogle Scholar
  35. 35.
    Gillis KD, Mossner R, Neher E (1996) Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16:1209–1220CrossRefPubMedGoogle Scholar
  36. 36.
    Gosso S, Turturici M, Franchino C, Colombo E, Pasquarelli A, Carbone E, Carabelli V (2014) Heterogeneous distribution of exocytotic microdomains in adrenal chromaffin cells resolved by high-density diamond ultra-microelectrode arrays. J Physiol 592:3215–3230CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Graham ME, O'Callaghan DW, McMahon HT, Burgoyne RD (2002) Dynamin-dependent and dynamin-independent processes contribute to the regulation of single vesicle release kinetics and quantal size. Proc Natl Acad Sci U S A 99:7124–7129CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85–100CrossRefPubMedGoogle Scholar
  39. 39.
    Horrigan FT, Bookman RJ (1994) Releasable pools and the kinetics of exocytosis in adrenal chromaffin cells. Neuron 13:1119–1129CrossRefPubMedGoogle Scholar
  40. 40.
    Jahn R, Sudhof TC (1999) Membrane fusion and exocytosis. Annu Rev Biochem 68:863–911CrossRefPubMedGoogle Scholar
  41. 41.
    Johns LM, Levitan ES, Shelden EA, Holz RW, Axelrod D (2001) Restriction of secretory granule motion near the plasma membrane of chromaffin cells. J Cell Biol 153:177–190CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Jun E, Kim SC, Song KB, Hwang DW, Lee JH, Shin SH, Hong SM, Park KM, Lee YJ (2017) Diagnostic value of chromogranin a in pancreatic neuroendocrine tumors depends on tumor size: a prospective observational study from a single institute. Surgery 162:120–130CrossRefPubMedGoogle Scholar
  43. 43.
    Kajiwara R, Sand O, Kidokoro Y, Barish ME, Iijima T (1998) Functional organization of chromaffin cells and cholinergic synaptic transmission in rat adrenal medulla. Jpn J Physiol 47:449–464CrossRefGoogle Scholar
  44. 44.
    Leszczyszyn DJ, Jankowski JA, Viveros OH, Diliberto EJ Jr, Near JA, Wightman RM (1990) Nicotinic receptor-mediated catecholamine secretion from individual chromaffin cells. Chemical evidence for exocytosis. J Biol Chem 265:14736–14737PubMedGoogle Scholar
  45. 45.
    Livett BG, Dean DM, Whelan LG, Udenfriend S, Rossier J (1981) Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature 289:317–319CrossRefPubMedGoogle Scholar
  46. 46.
    Machado JD, Segura F, Brioso MA, Borges R (2000) Nitric oxide modulates a late step of exocytosis. J Biol Chem 275:20274–20279CrossRefPubMedGoogle Scholar
  47. 47.
    Marcantoni A, Vandael DHF, Mahapatra S, Carabelli V, Sinnegger-Brauns MJ, Striessnig J, Carbone E (2010) Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. J Neurosci 30:491–504CrossRefPubMedGoogle Scholar
  48. 48.
    Maroto R, De la Fuente MT, Artalejo AR, Abad F, Lopez MG, Garcia-Sancho J, and Garcia AG. Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine. Eur J Pharmacol 270: 331–339, 1994Google Scholar
  49. 49.
    Martin AO, Mathieu MN, Chevillard C, Guerineau NC (2001) Gap junctions mediate electrical signaling and ensuing cytosolic Ca2+ increases between chromaffin cells in adrenal slices: a role in catecholamine release. J Neurosci 21:5397–5405PubMedGoogle Scholar
  50. 50.
    Marty A, Neher E (1985) Potassium channels in cultured bovine adrenal chromaffin cells. J Physiol 367:117–141CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Montesinos MS, Machado JD, Camacho M, Diaz J, Morales YG, Alvarez de la Rosa D, Carmona E, Castaneyra A, Viveros OH, O'Connor DT, Mahata SK, Borges R (2008) The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from chromogranin A null mouse. J Neurosci 28:3350–3358CrossRefPubMedGoogle Scholar
  52. 52.
    Mosharov EV, Gong LW, Khanna B, Sulzer D, Lindau M (2003) Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells. J Neurosci 23:5835–5845PubMedGoogle Scholar
  53. 53.
    Neco P, Giner D, del Mar Frances M, Viniegra S, and Gutierrez LM. Differential participation of actin- and tubulin-based vesicle transport systems during secretion in bovine chromaffin cells. Eur J Neurosci 18: 733–742, 2003Google Scholar
  54. 54.
    Neco P, Giner D, Viniegra S, Borges R, Villarroel A, Gutierrez LM (2004) New roles of myosin II during vesicle transport and fusion in chromaffin cells. J Biol Chem 279:27450–27457CrossRefPubMedGoogle Scholar
  55. 55.
    Neely A, Lingle CJ (1992) Two components of calcium-activated potassium current in rat adrenal chromaffin cells. J Physiol 453:97–131CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Neher E, Marty A (1982) Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. Proc Natl Acad Sci U S A 79:6712–6716CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Ngatchou AN, Kisler K, Fang Q, Walter AM, Zhao Y, Bruns D, Sorensen JB, Lindau M (2010) Role of the synaptobrevin C terminus in fusion pore formation. Proc Natl Acad Sci U S A 107:18463–18468CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    O'Connor DT, Bernstein KN (1984) Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 311:764–770CrossRefPubMedGoogle Scholar
  59. 59.
    Oheim M, Stuhmer W (2000) Tracking chromaffin granules on their way through the actin cortex. Eur Biophys J 29:67–89CrossRefPubMedGoogle Scholar
  60. 60.
    Rettig J, Neher E (2002) Emerging roles of presynaptic proteins in Ca++-triggered exocytosis. Science 298:781–785CrossRefPubMedGoogle Scholar
  61. 61.
    Schroeder TJ, Jankowski JA, Senyshyn J, Holz RW, Wightman RM (1994) Zones of exocytotic release on bovine adrenal medullary cells in culture. J Biol Chem 269:17215–17220PubMedGoogle Scholar
  62. 62.
    Scott RS, Bustillo D, Olivos-Oré LA, Cuchillo-Ibanez I, Barahona MV, Carbone E, Artalejo AR (2011) Contribution of BK channels to action potential repolarisation at minimal cytosolic Ca2+ concentration in chromaffin cells. Pflugers Archiv-European Journal of Physiology 462:545–557CrossRefPubMedGoogle Scholar
  63. 63.
    Smith CB, Eiden LE (2012) Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse? J Mol Neurosci 48:403–412CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Sorensen JB, Nagy G, Varoqueaux F, Nehring RB, Brose N, Wilson MC, Neher E (2003) Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23. Cell 114:75–86CrossRefPubMedGoogle Scholar
  65. 65.
    Stroth N, Holighaus Y, Ait-Ali D, Eiden LE (2011) PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Ann N Y Acad Sci 1220:49–59CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Travis ER, Wightman RM (1998) Spatio-temporal resolution of exocytosis from individual cells. Annu Rev Biophys Biomol Struct 27:77–103CrossRefPubMedGoogle Scholar
  67. 67.
    Trifaro JM (1977) Common mechanisms of hormone secretion. Annu Rev Pharmacol Toxicol 17:27–47CrossRefPubMedGoogle Scholar
  68. 68.
    Tsujimoto A, Nishikawa T (1975) Further evidence for nicotinic and muscarinic receptors and their interaction in dog adrenal medulla. Eur J Pharmacol 34:337–344CrossRefPubMedGoogle Scholar
  69. 69.
    Vandael DH, Marcantoni A, Carbone E (2015) Cav1.3 channels as key regulators of neuron-like firings and catecholamine release in chromaffin cells. Curr Mol Pharmacol 8:149–161CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283–357CrossRefPubMedGoogle Scholar
  71. 71.
    Voets T, Neher E, Moser T (1999) Mechanisms underlying phasic and sustained secretion in chromaffin cells from mouse adrenal slices. Neuron 23:607–615CrossRefPubMedGoogle Scholar
  72. 72.
    Wakade AR (1998) Multiple transmitter control of catecholamine secretion in rat adrenal medulla. Adv Pharmacol 42:595–598CrossRefPubMedGoogle Scholar
  73. 73.
    Watanabe T, Masuo Y, Matsumoto H, Suzuki N, Ohtaki T, Masuda Y, Kitada C, Tsuda M, Fujino M (1992) Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline. Biochem Biophys Res Commun 182:403–411CrossRefPubMedGoogle Scholar
  74. 74.
    Wightman RM, Jankowski JA, Kennedy RT, Kawagoe KT, Schroeder TJ, Leszczyszyn DJ, Near JA, Diliberto EJ Jr, Viveros OH (1991) Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. Proc Natl Acad Sci U S A 88:10754–10758CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Unidad de Farmacología, Facultad de MedicinaUniversidad de La LagunaSan Cristóbal de La LagunaSpain
  2. 2.Instituto de Bio-Orgánica Antonio GonzálezUniversidad de La LagunaSan Cristóbal de La LagunaSpain
  3. 3.Departamento de Farmacología y TerapéuticaUniversidad Autónoma de MadridMadridSpain
  4. 4.Instituto Teófilo HernandoUniversidad Autónoma de MadridMadridSpain
  5. 5.Department of Drug ScienceLab of Cellular Physiology and Molecular NeuroscienceTorinoItaly

Personalised recommendations